MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Predictors of different progressive trajectories of cognition in Parkinson’s disease

    G. Smith, R. Zielinski, C. Venuto, M. Javidnia, K. Kieburtz (Rochester, NY, USA)

    Objective: To identify subgroups of people living with Parkinson’s disease (PD) who have statistically distinct trajectories of Montreal Cognitive Assessment (MoCA) scores over four years,…
  • MDS Virtual Congress 2020

    Beta-Glucocerebrosidase Activity in GBA-linked Parkinson’s Disease: The Type of Mutation Matters

    Y.E Huh, M.S Chiang, J. Locascio, Z. Liao, G. Liu, K. Choudhury, Y. Kuras, I. Tuncali, A. Videnovic, A. Hunt, M. Schwarzschild, A. Hung, T. Herrington, M. Hayes, B. Hyman, A.M Wills, S. Gomperts, J. Growdon, S. Sardi, C. Scherzer (Boston, MA, USA)

    Objective: To test the relationship between clinically relevant types of GBA mutations (none, risk variants, mild mutations, severe mutations) and beta-glucocerebrosidase activity in patients with…
  • MDS Virtual Congress 2020

    A novel likely pathogenic SNCA variant associated with Parkinson’s disease

    B. Minafra, G. Buongarzone, S. Gana, M.L Valente, I. Palmieri, T. Biagini, M. Plumari, M. Avenali, R. Zangaglia, T. Mazza, C. Cereda, C. Pacchetti, E.M Valente (Pavia, Italy)

    Objective: To report a novel SNCA likely pathogenic variant. Background: The A53T mutation in the SNCA gene, encoding alpha-synuclein (a-syn), was the first established genetic…
  • MDS Virtual Congress 2020

    GCH1 variants contribute to risk and earlier age at onset in Parkinson’s disease

    Y. Zhao, H. Pan, Q. Sun, Q. Xu, X. Yan, J. Li, B. Tang, J. Guo (Changsha, China)

    Objective: Our aim was to identify the potential role of known genetic components of GCH1, including rare and common variants in coding and non-coding regions,…
  • MDS Virtual Congress 2020

    Diagnostic value of vagus nerve ultrasound in Parkinson’s disease

    M. Abo Srea, N.A Kishk, R. Soliman, A. Alsayyad, M. Oraby (Beni-Suef, Egypt)

    Objective: To detect by the ultrasound (US) the possible presence of vagus nerve atrophy in patients with PD and its relation to severity of motor,…
  • MDS Virtual Congress 2020

    Noradrenergic terminal and locus coeruleus cell loss may be uncoupled in Parkinson’s disease – a PET and MRI multi-modal imaging study

    M. Kinnerup, C. Doppler, E. Farrher, T. Fedorova, J. Schaldemose, K. Knudsen, R. Isamail, A. Hansen, K. Stær, G. Fink, J. Shah, D. Brooks, A. Nahimi, P. Borghammer, M. Sommerauer (Aarhus, Denmark)

    Objective: To assess multimodal imaging of the noradrenergic system: magnetic resonance imaging (MRI) neuromelanin contrast of the locus coeruleus (LC) and noradrenalin transporter density with…
  • MDS Virtual Congress 2020

    Alterations in functional networks contribute to depression in Parkinson’s disease: A resting-state functional magnetic resonance imaging study

    Y. Qiu, L. Wang (Guangzhou, China)

    Objective: The aim of this research was to investigate alterations in functional brain networks in PD patients with depression (DPD) and their association with demographic…
  • MDS Virtual Congress 2020

    Loss of cortical inhibition in Parkinson’s disease

    C. Ammann, M. Dileone, C. Pagge, V. Catanzaro, D. Mata-Marín, F. Hernández-Fernández, M.G Monje, A. Sánchez-Ferro, B. Fernández-Rodríguez, C. Gasca-Salas, J.U Máñez-Miró, R. Martínez-Fernández, L. Vela, F. Alonso-Frech, A. Oliviero, J.A Obeso, G. Foffani (Móstoles, Spain)

    Objective: To evaluate motor cortex inhibition at different stages of Parkinson’s disease (PD). Background: In PD, striatal dopamine depletion produces profound alterations in the neural…
  • MDS Virtual Congress 2020

    Pain syndrome in Parkinson’s disease: neurophysiological and MRI morphometric features

    O. Alenikova, I. Goursky, N. Alenikov (Minsk, Belarus)

    Objective: Investigation of the neurophysiological disorders and identify their structural correlates in the brain by MRI studies with using voxel-based morphometry to reveal subtle changes…
  • MDS Virtual Congress 2020

    Does constipation predict cognitive impairment and dementia in de novo Parkinson’s disease patients? A multi-cohort longitudinal data analysis

    V. Leta, D. Urso, L. Batzu, D. Weintraub, D. Aarsland, D. van Wamelen, T. Yousaf, P. Martinez-Martin, C. Rodriguez-Blazquez, A. Rizos, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To investigate if constipation predicts the development of cognitive impairment (CI) and dementia in de novo Parkinson’s disease (PD). Background: Constipation is one of…
  • « Previous Page
  • 1
  • …
  • 109
  • 110
  • 111
  • 112
  • 113
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #22901 (not found)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley